Intranasal Ketamine for Pediatric Procedural Sedation: a Feasibility Study

Stopped early · Early Phase 1

Conditions studied: Failed Moderate Sedation During Procedure, Ketamine Adverse Reaction

In brief

The purpose of this study is to evaluate the feasibility of intranasal ketamine for adequate sedation of children undergoing minor procedures in the Emergency Department. An intranasal dose of 10mg/kg will be used in patients requiring procedural sedation. The investigators hypothesize that this dose of intranasal ketamine will be able to provide adequate sedation and analgesia for the physician to successfully complete the planned diagnostic or therapeutic intervention (Pediatr Emer Care 2012;28: 767-70). The primary endpoint will be successful sedation, as defined by the ability to complete the planned procedure without rescue medication, which includes re-dosing of the same medication.

Key facts

Study ID
NCT03067974
Run by
University of Arizona
People needed
10
Starts
2017-09-21
Expected to finish
2019-01-22
Last updated by the study team
2019-01-28

Who can join

Age: 2 and older, up to 7. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.